Scientific publications 2019

Expression of miRNAs from the Imprinted DLK1/DIO3 Locus Signals the Osteogenic Potential of Human Pluripotent Stem Cells.

Barrault L, Gide J, Qing T, Lesueur L, Tost J, Denis JA, Cailleret M, Aubry L, Peschanski M, Martinat C, Baghdoyan S.

Cells. 2019 Nov 26;8(12). pii: E1523. doi: 10.3390/cells8121523.

 

Clinical-grade production and safe delivery of human ESC derived RPE sheets in primates and rodents.

Ben M’Barek K, Bertin S, Brazhnikova E, Jaillard C, Habeler W, Plancheron A, Fovet CM, Demilly J, Jarraya M, Bejanariu A, Sahel JA, Peschanski M, Goureau O, Monville C.

Biomaterials. 2019 Nov 6:119603. doi: 10.1016/j.biomaterials.2019.119603. [Epub ahead of print]

 

Developing Cell-Based Therapies for RPE-Associated Degenerative Eye Diseases.

Ben M’Barek K, Habeler W, Regent F, Monville C.

Adv Exp Med Biol. 2019;1186:55-97. doi: 10.1007/978-3-030-28471-8_3. Review

 

Induced pluripotent stem cells-derived neurons from patients with Friedreich ataxia exhibit differential sensitivity to resveratrol and nicotinamide.

Georges P, Boza-Moran MG, Gide J, Pêche GA, Forêt B, Bayot A, Rustin P, Peschanski M, Martinat C, Aubry L.

Sci Rep. 2019 Oct 10;9(1):14568. doi: 10.1038/s41598-019-49870-y.

 

MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates.

Aron Badin R, Bugi A, Williams S, Vadori M, Michael M, Jan C, Nassi A, Lecourtois S, Blancher A, Cozzi E, Hantraye P, Perrier AL.

Nat Commun. 2019 Sep 25;10(1):4357. doi: 10.1038/s41467-019-12324-0.

 

CTIP2-Regulated Reduction in PKA-Dependent DARPP32 Phosphorylation in Human Medium Spiny Neurons: Implications for Huntington Disease.

Fjodorova M, Louessard M, Li Z, De La Fuente DC, Dyke E, Brooks SP, Perrier AL, Li M.

Stem Cell Reports. 2019 Sep 10;13(3):448-457. doi: 10.1016/j.stemcr.2019.07.015. Epub 2019 Aug 22.

 

Automation of human pluripotent stem cell differentiation toward retinal pigment epithelial cells for large-scale productions.

Regent F, Morizur L, Lesueur L, Habeler W, Plancheron A, Ben M’Barek K, Monville C.

Sci Rep. 2019 Jul 23;9(1):10646. doi: 10.1038/s41598-019-47123-6.

 

Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation.

Hoch L, Henriques SF, Bruge C, Marsolier J, Benabides M, Bourg N, Tournois J, Mahé G, Morizur L, Jarrige M, Bigot A, Richard I, Nissan X.

Sci Rep. 2019 May 6;9(1):6915. doi: 10.1038/s41598-019-43399-w.

 

Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering.

Ben M’Barek K, Monville C.

Stem Cells Int. 2019 Jan 23;2019:4568979. doi: 10.1155/2019/4568979. eCollection 2019. Review.

 

Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins.

Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J, Mournetas V, Massouridès E, Sohier TJM, Corbin A, Aubé F, Teixeira M, Pinset C, Schaeffer L, Legube G, Cosset FL, Verhoeyen E, Ohlmann T, Ricci EP.

Nat Commun. 2019 Jan 3;10(1):45. doi: 10.1038/s41467-018-07845-z.

 

Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network.

Gribaudo S, Tixador P, Bousset L, Fenyi A, Lino P, Melki R, Peyrin JM, Perrier AL.

Stem Cell Reports. 2019 Jan 9. pii: S2213-6711(18)30526-5.

 

[Pharmacological research and pluripotent stem cells: from the innovative experimental paradigm to the successful clinical trial].

Baghdoyan S, Bassez G, Audureau E, Peschanski M.

Med Sci (Paris). 2019 Jan;35(1):26-29.

 

Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1.

Maury Y, Poydenot P, Brinon B, Lesueur L, Gide J, Roquevière S, Côme J, Polvèche H, Auboeuf D, Alexandre Denis J, Pietu G, Furling D, Lechuga M, Baghdoyan S, Peschanski M, Martinat C.

iScience. 2019 Jan 25;11:258-271.